These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12270182)

  • 41. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
    O'Reilly EK; Kreuzer KN
    Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
    Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA Interaction and photonicking properties of DNA-targeted acridine (2,2'-Bipyridine)platinum(II) complexes.
    Gude L; Fernández MJ; Grant KB; Lorente A
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3135-9. PubMed ID: 12372518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
    Etiévant C; Kruczynski A; Barret JM; Perrin D; van Hille B; Guminski Y; Hill BT
    Cancer Chemother Pharmacol; 2000; 46(2):101-13. PubMed ID: 10972479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
    Constantinou AI; Husband A
    Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands.
    Bielawski K; Bielawska A; Popławska B; Bołkun-Skórnicka U
    Acta Pol Pharm; 2008; 65(3):363-70. PubMed ID: 18646556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
    Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage.
    Gatto B; Richter S; Moro S; Capranico G; Palumbo M
    Nucleic Acids Res; 2001 Oct; 29(20):4224-30. PubMed ID: 11600711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flavonoids in Helichrysum pamphylicum inhibit mammalian type I DNA topoisomerase.
    Topcu Z; Ozturk B; Kucukoglu O; Kilinc E
    Z Naturforsch C J Biosci; 2008; 63(1-2):69-74. PubMed ID: 18386491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38.
    Bailly C; Laine W; Baldeyrou B; Demarquay D; Huchet M; Coulomb H; Lanco C; Lavergne O; Bigg DC
    Anticancer Drug Des; 2001 Feb; 16(1):27-36. PubMed ID: 11762642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene.
    Hutt AM; Kalf GF
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1265-9. PubMed ID: 9118903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human DNA topoisomerase I poisoning activity of bis-1-aminomethylnaphtalenes. A correlation with their cytotoxic activity.
    Romano A; Mongelli E; Bruno AM; Gaozza C; Coussio J; Ciccia G
    Pharmazie; 2000 Aug; 55(8):612-4. PubMed ID: 10989841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
    Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA
    Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
    Tomicic MT; Christmann M; Kaina B
    Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols.
    Dorr RT; Bellamy W; Liddil JD; Baker A; Bair KW
    Anticancer Drug Des; 1998 Oct; 13(7):825-35. PubMed ID: 9807165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides.
    Duca M; Guianvarc'h D; Oussedik K; Halby L; Garbesi A; Dauzonne D; Monneret C; Osheroff N; Giovannangeli C; Arimondo PB
    Nucleic Acids Res; 2006; 34(6):1900-11. PubMed ID: 16598074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
    Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
    Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks.
    Senarisoy M; Canturk P; Zencir S; Baran Y; Topcu Z
    Cell Biochem Biophys; 2013 May; 66(1):199-204. PubMed ID: 23161103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation.
    Zheng Y; Sanche L
    Radiat Res; 2009 Jul; 172(1):114-9. PubMed ID: 19580513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.